Identification of ribosomal protein L30 as an uncharacterized antimicrobial protein

Several ribosomal proteins have been shown to adopt for an antimicrobial function as antimicrobial proteins (AMPs). However, information as such is rather limited and their mode of action remains ill-defined. Here we demonstrated that amphioxus RPL30, BjRPL30, was a previously uncharacterized AMP, w...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Developmental and comparative immunology 2021-07, Vol.120, p.104067-104067, Article 104067
Hauptverfasser: Chen, Ying, Yao, Lan, Wang, Yunsheng, Ji, Xiaohan, Gao, Zhan, Zhang, Shicui, Ji, Guangdong
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 104067
container_issue
container_start_page 104067
container_title Developmental and comparative immunology
container_volume 120
creator Chen, Ying
Yao, Lan
Wang, Yunsheng
Ji, Xiaohan
Gao, Zhan
Zhang, Shicui
Ji, Guangdong
description Several ribosomal proteins have been shown to adopt for an antimicrobial function as antimicrobial proteins (AMPs). However, information as such is rather limited and their mode of action remains ill-defined. Here we demonstrated that amphioxus RPL30, BjRPL30, was a previously uncharacterized AMP, which was not only capable of binding Gram-negative and Gram-positive bacteria via interaction with LPS, LTA and PGN but also capable of killing the bacteria. We also showed that the residues positioned at 2–46 formed the core region for the antimicrobial activity of BjRPL30. Notably, both the hydrophobic ratio and net charge as well as 3D structures of the residues corresponding to BjRPL302-27 and BjRPL3023-46 from both eukaryotic and prokaryotic RPL30 proteins were closely similar to those of BjRPL302-27 and BjRPL3023-46, suggesting the antibacterial activity of RPL30 was highly conserved. This was further corroborated by the fact that the synthesized counterparts human RPL5-30 and RPL26-49 also had antibacterial activity. We show that the recombinant protein BjRPL30 executes antimicrobial function in vitro by a kind of membranolytic action including interaction with bacterial membrane through LPS, LTA and PGN as well as induction of membrane depolarization. Finally, we found that neither BjRPL30 nor its truncated form BjRPL302-27 and BjRPL3023-46 had hemolytic activity towards human red blood cells, making them promising lead molecules for the design of novel AMPs against bacteria. Altogether, these indicated that RPL30 is a member of AMP which has ancient origin and is highly conserve throughout evolution. •Amphioxus ribosomal protein L30, BjRPL30, was identified as a new AMP.•Amino acids positioned at 2–27 and 23–46 formed the core region for antimicrobial activity of BjRPL30.•BjRPL30 showed membrane selectivity towards bacterial cells but not towards mammalian cells.•Emergence of antibacterial activity of RPL30 was traced to its prokaryotic homologue RPL30e.
doi_str_mv 10.1016/j.dci.2021.104067
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2501260860</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0145305X21000756</els_id><sourcerecordid>2522847203</sourcerecordid><originalsourceid>FETCH-LOGICAL-c381t-4b530edeec6b3b39c7e9ffcab9e2714711542fdcaa45e70eafc30c7b5c20ec853</originalsourceid><addsrcrecordid>eNp9kEGL1DAUx4O4uOPoB_AiBS976exL0jQtnmRwdWDAgwreQvr6iinTZkzSBffTb5auCnswl0fC7_1f3o-xNxx2HHh9Pe56dDsBgud7BbV-xja80W0J0LTP2QZ4pUoJ6sclexnjCPk0HF6wSyk1KN3Chn099DQnNzi0yfm58EMRXOejn-ypOAefyM3FUUJhY2HnYpnxpw0WEwV3R31-Sm5yGHzn_vGv2MVgT5FeP9Yt-37z8dv-c3n88umw_3AsUTY8lVWnJFBPhHUnO9mipnYY0HYtCc0rzbmqxNCjtZUiDWQHlIC6UyiAsFFyy67W3Dz310IxmclFpNPJzuSXaIQCLmpoasjouyfo6Jcw599lSoim0gJkpvhK5YViDDSYc3CTDb8NB_Ng3IwmGzcPxs1qPPe8fUxeuon6vx1_FGfg_QpQVnHrKJiIjmak3gXCZHrv_hN_D5qmkUU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2522847203</pqid></control><display><type>article</type><title>Identification of ribosomal protein L30 as an uncharacterized antimicrobial protein</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Chen, Ying ; Yao, Lan ; Wang, Yunsheng ; Ji, Xiaohan ; Gao, Zhan ; Zhang, Shicui ; Ji, Guangdong</creator><creatorcontrib>Chen, Ying ; Yao, Lan ; Wang, Yunsheng ; Ji, Xiaohan ; Gao, Zhan ; Zhang, Shicui ; Ji, Guangdong</creatorcontrib><description>Several ribosomal proteins have been shown to adopt for an antimicrobial function as antimicrobial proteins (AMPs). However, information as such is rather limited and their mode of action remains ill-defined. Here we demonstrated that amphioxus RPL30, BjRPL30, was a previously uncharacterized AMP, which was not only capable of binding Gram-negative and Gram-positive bacteria via interaction with LPS, LTA and PGN but also capable of killing the bacteria. We also showed that the residues positioned at 2–46 formed the core region for the antimicrobial activity of BjRPL30. Notably, both the hydrophobic ratio and net charge as well as 3D structures of the residues corresponding to BjRPL302-27 and BjRPL3023-46 from both eukaryotic and prokaryotic RPL30 proteins were closely similar to those of BjRPL302-27 and BjRPL3023-46, suggesting the antibacterial activity of RPL30 was highly conserved. This was further corroborated by the fact that the synthesized counterparts human RPL5-30 and RPL26-49 also had antibacterial activity. We show that the recombinant protein BjRPL30 executes antimicrobial function in vitro by a kind of membranolytic action including interaction with bacterial membrane through LPS, LTA and PGN as well as induction of membrane depolarization. Finally, we found that neither BjRPL30 nor its truncated form BjRPL302-27 and BjRPL3023-46 had hemolytic activity towards human red blood cells, making them promising lead molecules for the design of novel AMPs against bacteria. Altogether, these indicated that RPL30 is a member of AMP which has ancient origin and is highly conserve throughout evolution. •Amphioxus ribosomal protein L30, BjRPL30, was identified as a new AMP.•Amino acids positioned at 2–27 and 23–46 formed the core region for antimicrobial activity of BjRPL30.•BjRPL30 showed membrane selectivity towards bacterial cells but not towards mammalian cells.•Emergence of antibacterial activity of RPL30 was traced to its prokaryotic homologue RPL30e.</description><identifier>ISSN: 0145-305X</identifier><identifier>EISSN: 1879-0089</identifier><identifier>DOI: 10.1016/j.dci.2021.104067</identifier><identifier>PMID: 33705790</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Aeromonas hydrophila - drug effects ; Amino Acid Sequence ; Amphioxus ; Animals ; Antibacterial activity ; Antimicrobial activity ; Antimicrobial agents ; Antimicrobial peptides ; Bacteria ; Depolarization ; Erythrocytes ; Erythrocytes - drug effects ; Gram-positive bacteria ; Hemolysis ; Humans ; Hydrophobicity ; Lancelets - genetics ; Lancelets - immunology ; Lipopolysaccharides ; Membrane potential ; Membranes ; Microbial Sensitivity Tests ; Mode of action ; Moonlighting protein ; Proteins ; Recombinant Proteins - genetics ; Recombinant Proteins - isolation &amp; purification ; Recombinant Proteins - metabolism ; Residues ; Ribosomal protein L30 ; Ribosomal proteins ; Ribosomal Proteins - genetics ; Ribosomal Proteins - isolation &amp; purification ; Ribosomal Proteins - pharmacology ; Staphylococcus aureus - drug effects</subject><ispartof>Developmental and comparative immunology, 2021-07, Vol.120, p.104067-104067, Article 104067</ispartof><rights>2021 Elsevier Ltd</rights><rights>Copyright © 2021 Elsevier Ltd. All rights reserved.</rights><rights>Copyright Elsevier Science Ltd. Jul 2021</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c381t-4b530edeec6b3b39c7e9ffcab9e2714711542fdcaa45e70eafc30c7b5c20ec853</citedby><cites>FETCH-LOGICAL-c381t-4b530edeec6b3b39c7e9ffcab9e2714711542fdcaa45e70eafc30c7b5c20ec853</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.dci.2021.104067$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33705790$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chen, Ying</creatorcontrib><creatorcontrib>Yao, Lan</creatorcontrib><creatorcontrib>Wang, Yunsheng</creatorcontrib><creatorcontrib>Ji, Xiaohan</creatorcontrib><creatorcontrib>Gao, Zhan</creatorcontrib><creatorcontrib>Zhang, Shicui</creatorcontrib><creatorcontrib>Ji, Guangdong</creatorcontrib><title>Identification of ribosomal protein L30 as an uncharacterized antimicrobial protein</title><title>Developmental and comparative immunology</title><addtitle>Dev Comp Immunol</addtitle><description>Several ribosomal proteins have been shown to adopt for an antimicrobial function as antimicrobial proteins (AMPs). However, information as such is rather limited and their mode of action remains ill-defined. Here we demonstrated that amphioxus RPL30, BjRPL30, was a previously uncharacterized AMP, which was not only capable of binding Gram-negative and Gram-positive bacteria via interaction with LPS, LTA and PGN but also capable of killing the bacteria. We also showed that the residues positioned at 2–46 formed the core region for the antimicrobial activity of BjRPL30. Notably, both the hydrophobic ratio and net charge as well as 3D structures of the residues corresponding to BjRPL302-27 and BjRPL3023-46 from both eukaryotic and prokaryotic RPL30 proteins were closely similar to those of BjRPL302-27 and BjRPL3023-46, suggesting the antibacterial activity of RPL30 was highly conserved. This was further corroborated by the fact that the synthesized counterparts human RPL5-30 and RPL26-49 also had antibacterial activity. We show that the recombinant protein BjRPL30 executes antimicrobial function in vitro by a kind of membranolytic action including interaction with bacterial membrane through LPS, LTA and PGN as well as induction of membrane depolarization. Finally, we found that neither BjRPL30 nor its truncated form BjRPL302-27 and BjRPL3023-46 had hemolytic activity towards human red blood cells, making them promising lead molecules for the design of novel AMPs against bacteria. Altogether, these indicated that RPL30 is a member of AMP which has ancient origin and is highly conserve throughout evolution. •Amphioxus ribosomal protein L30, BjRPL30, was identified as a new AMP.•Amino acids positioned at 2–27 and 23–46 formed the core region for antimicrobial activity of BjRPL30.•BjRPL30 showed membrane selectivity towards bacterial cells but not towards mammalian cells.•Emergence of antibacterial activity of RPL30 was traced to its prokaryotic homologue RPL30e.</description><subject>Aeromonas hydrophila - drug effects</subject><subject>Amino Acid Sequence</subject><subject>Amphioxus</subject><subject>Animals</subject><subject>Antibacterial activity</subject><subject>Antimicrobial activity</subject><subject>Antimicrobial agents</subject><subject>Antimicrobial peptides</subject><subject>Bacteria</subject><subject>Depolarization</subject><subject>Erythrocytes</subject><subject>Erythrocytes - drug effects</subject><subject>Gram-positive bacteria</subject><subject>Hemolysis</subject><subject>Humans</subject><subject>Hydrophobicity</subject><subject>Lancelets - genetics</subject><subject>Lancelets - immunology</subject><subject>Lipopolysaccharides</subject><subject>Membrane potential</subject><subject>Membranes</subject><subject>Microbial Sensitivity Tests</subject><subject>Mode of action</subject><subject>Moonlighting protein</subject><subject>Proteins</subject><subject>Recombinant Proteins - genetics</subject><subject>Recombinant Proteins - isolation &amp; purification</subject><subject>Recombinant Proteins - metabolism</subject><subject>Residues</subject><subject>Ribosomal protein L30</subject><subject>Ribosomal proteins</subject><subject>Ribosomal Proteins - genetics</subject><subject>Ribosomal Proteins - isolation &amp; purification</subject><subject>Ribosomal Proteins - pharmacology</subject><subject>Staphylococcus aureus - drug effects</subject><issn>0145-305X</issn><issn>1879-0089</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEGL1DAUx4O4uOPoB_AiBS976exL0jQtnmRwdWDAgwreQvr6iinTZkzSBffTb5auCnswl0fC7_1f3o-xNxx2HHh9Pe56dDsBgud7BbV-xja80W0J0LTP2QZ4pUoJ6sclexnjCPk0HF6wSyk1KN3Chn099DQnNzi0yfm58EMRXOejn-ypOAefyM3FUUJhY2HnYpnxpw0WEwV3R31-Sm5yGHzn_vGv2MVgT5FeP9Yt-37z8dv-c3n88umw_3AsUTY8lVWnJFBPhHUnO9mipnYY0HYtCc0rzbmqxNCjtZUiDWQHlIC6UyiAsFFyy67W3Dz310IxmclFpNPJzuSXaIQCLmpoasjouyfo6Jcw599lSoim0gJkpvhK5YViDDSYc3CTDb8NB_Ng3IwmGzcPxs1qPPe8fUxeuon6vx1_FGfg_QpQVnHrKJiIjmak3gXCZHrv_hN_D5qmkUU</recordid><startdate>202107</startdate><enddate>202107</enddate><creator>Chen, Ying</creator><creator>Yao, Lan</creator><creator>Wang, Yunsheng</creator><creator>Ji, Xiaohan</creator><creator>Gao, Zhan</creator><creator>Zhang, Shicui</creator><creator>Ji, Guangdong</creator><general>Elsevier Ltd</general><general>Elsevier Science Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T5</scope><scope>C1K</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>202107</creationdate><title>Identification of ribosomal protein L30 as an uncharacterized antimicrobial protein</title><author>Chen, Ying ; Yao, Lan ; Wang, Yunsheng ; Ji, Xiaohan ; Gao, Zhan ; Zhang, Shicui ; Ji, Guangdong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c381t-4b530edeec6b3b39c7e9ffcab9e2714711542fdcaa45e70eafc30c7b5c20ec853</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Aeromonas hydrophila - drug effects</topic><topic>Amino Acid Sequence</topic><topic>Amphioxus</topic><topic>Animals</topic><topic>Antibacterial activity</topic><topic>Antimicrobial activity</topic><topic>Antimicrobial agents</topic><topic>Antimicrobial peptides</topic><topic>Bacteria</topic><topic>Depolarization</topic><topic>Erythrocytes</topic><topic>Erythrocytes - drug effects</topic><topic>Gram-positive bacteria</topic><topic>Hemolysis</topic><topic>Humans</topic><topic>Hydrophobicity</topic><topic>Lancelets - genetics</topic><topic>Lancelets - immunology</topic><topic>Lipopolysaccharides</topic><topic>Membrane potential</topic><topic>Membranes</topic><topic>Microbial Sensitivity Tests</topic><topic>Mode of action</topic><topic>Moonlighting protein</topic><topic>Proteins</topic><topic>Recombinant Proteins - genetics</topic><topic>Recombinant Proteins - isolation &amp; purification</topic><topic>Recombinant Proteins - metabolism</topic><topic>Residues</topic><topic>Ribosomal protein L30</topic><topic>Ribosomal proteins</topic><topic>Ribosomal Proteins - genetics</topic><topic>Ribosomal Proteins - isolation &amp; purification</topic><topic>Ribosomal Proteins - pharmacology</topic><topic>Staphylococcus aureus - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Ying</creatorcontrib><creatorcontrib>Yao, Lan</creatorcontrib><creatorcontrib>Wang, Yunsheng</creatorcontrib><creatorcontrib>Ji, Xiaohan</creatorcontrib><creatorcontrib>Gao, Zhan</creatorcontrib><creatorcontrib>Zhang, Shicui</creatorcontrib><creatorcontrib>Ji, Guangdong</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Immunology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Developmental and comparative immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Ying</au><au>Yao, Lan</au><au>Wang, Yunsheng</au><au>Ji, Xiaohan</au><au>Gao, Zhan</au><au>Zhang, Shicui</au><au>Ji, Guangdong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Identification of ribosomal protein L30 as an uncharacterized antimicrobial protein</atitle><jtitle>Developmental and comparative immunology</jtitle><addtitle>Dev Comp Immunol</addtitle><date>2021-07</date><risdate>2021</risdate><volume>120</volume><spage>104067</spage><epage>104067</epage><pages>104067-104067</pages><artnum>104067</artnum><issn>0145-305X</issn><eissn>1879-0089</eissn><abstract>Several ribosomal proteins have been shown to adopt for an antimicrobial function as antimicrobial proteins (AMPs). However, information as such is rather limited and their mode of action remains ill-defined. Here we demonstrated that amphioxus RPL30, BjRPL30, was a previously uncharacterized AMP, which was not only capable of binding Gram-negative and Gram-positive bacteria via interaction with LPS, LTA and PGN but also capable of killing the bacteria. We also showed that the residues positioned at 2–46 formed the core region for the antimicrobial activity of BjRPL30. Notably, both the hydrophobic ratio and net charge as well as 3D structures of the residues corresponding to BjRPL302-27 and BjRPL3023-46 from both eukaryotic and prokaryotic RPL30 proteins were closely similar to those of BjRPL302-27 and BjRPL3023-46, suggesting the antibacterial activity of RPL30 was highly conserved. This was further corroborated by the fact that the synthesized counterparts human RPL5-30 and RPL26-49 also had antibacterial activity. We show that the recombinant protein BjRPL30 executes antimicrobial function in vitro by a kind of membranolytic action including interaction with bacterial membrane through LPS, LTA and PGN as well as induction of membrane depolarization. Finally, we found that neither BjRPL30 nor its truncated form BjRPL302-27 and BjRPL3023-46 had hemolytic activity towards human red blood cells, making them promising lead molecules for the design of novel AMPs against bacteria. Altogether, these indicated that RPL30 is a member of AMP which has ancient origin and is highly conserve throughout evolution. •Amphioxus ribosomal protein L30, BjRPL30, was identified as a new AMP.•Amino acids positioned at 2–27 and 23–46 formed the core region for antimicrobial activity of BjRPL30.•BjRPL30 showed membrane selectivity towards bacterial cells but not towards mammalian cells.•Emergence of antibacterial activity of RPL30 was traced to its prokaryotic homologue RPL30e.</abstract><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>33705790</pmid><doi>10.1016/j.dci.2021.104067</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0145-305X
ispartof Developmental and comparative immunology, 2021-07, Vol.120, p.104067-104067, Article 104067
issn 0145-305X
1879-0089
language eng
recordid cdi_proquest_miscellaneous_2501260860
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Aeromonas hydrophila - drug effects
Amino Acid Sequence
Amphioxus
Animals
Antibacterial activity
Antimicrobial activity
Antimicrobial agents
Antimicrobial peptides
Bacteria
Depolarization
Erythrocytes
Erythrocytes - drug effects
Gram-positive bacteria
Hemolysis
Humans
Hydrophobicity
Lancelets - genetics
Lancelets - immunology
Lipopolysaccharides
Membrane potential
Membranes
Microbial Sensitivity Tests
Mode of action
Moonlighting protein
Proteins
Recombinant Proteins - genetics
Recombinant Proteins - isolation & purification
Recombinant Proteins - metabolism
Residues
Ribosomal protein L30
Ribosomal proteins
Ribosomal Proteins - genetics
Ribosomal Proteins - isolation & purification
Ribosomal Proteins - pharmacology
Staphylococcus aureus - drug effects
title Identification of ribosomal protein L30 as an uncharacterized antimicrobial protein
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T06%3A17%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Identification%20of%20ribosomal%20protein%20L30%20as%20an%20uncharacterized%20antimicrobial%20protein&rft.jtitle=Developmental%20and%20comparative%20immunology&rft.au=Chen,%20Ying&rft.date=2021-07&rft.volume=120&rft.spage=104067&rft.epage=104067&rft.pages=104067-104067&rft.artnum=104067&rft.issn=0145-305X&rft.eissn=1879-0089&rft_id=info:doi/10.1016/j.dci.2021.104067&rft_dat=%3Cproquest_cross%3E2522847203%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2522847203&rft_id=info:pmid/33705790&rft_els_id=S0145305X21000756&rfr_iscdi=true